Clinical Trials
10 trialsNCT03740165 2026-05-04
KEYLYNK-001
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT05116189 2026-03-09
KEYNOTE-B96
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting
NCT02253316 2025-11-10
Phase II Study of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma
Washington University School of Medicine
Phase 2 Active not recruiting
NCT00597909 2024-12-17
Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy
Amgen
Phase 2 Terminated
NCT04782856 2024-06-14
Energy Metabolism in Thyroidectomized Patients
Virginia Commonwealth University
Phase 2 Completed
NCT03824808 2023-10-25
Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery
University of Missouri-Columbia
Phase 4 Terminated
NCT04863248 2023-04-14
PRESERVE 4
G1 Therapeutics, Inc.
Phase 2 Terminated
NCT01384877 2019-07-12
Subcutaneous Lidocaine For Cancer-Related Pain
British Columbia Cancer Agency
Phase 2/3 Completed
NCT02012608 2019-05-29
Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy
University of Arkansas
Phase 2 Terminated
NCT00989781 2018-06-04
Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome
University of California, San Diego
Phase NA Completed